Legal Representation
Attorney
Anthony P. Venturino
USPTO Deadlines
Next Deadline
2485 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2012-05-01)
Due Date
May 01, 2032
Grace Period Ends
November 01, 2032
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 11, 2023 | INNP | P | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Jul 12, 2023 | INPC | P | INVALIDATION PROCESSED |
| Jul 12, 2023 | INPS | P | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Jun 13, 2023 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Oct 13, 2022 | 71AG | O | REGISTERED-SEC.71 ACCEPTED |
| Oct 13, 2022 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Oct 12, 2022 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Apr 22, 2022 | ES71 | I | TEAS SECTION 71 RECEIVED |
| Nov 20, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| May 1, 2021 | REM4 | E | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| Aug 24, 2020 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED |
| May 9, 2018 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| May 9, 2018 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| May 8, 2018 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Apr 27, 2018 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED |
| May 1, 2017 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Nov 14, 2012 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Oct 30, 2012 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Aug 31, 2012 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Aug 1, 2012 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Aug 1, 2012 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Aug 1, 2012 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| May 1, 2012 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Apr 23, 2012 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Mar 28, 2012 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Mar 28, 2012 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Feb 14, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 14, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 25, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 25, 2012 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Jan 25, 2012 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Jan 9, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jan 6, 2012 | ALIE | A | ASSIGNED TO LIE |
| Dec 16, 2011 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Dec 16, 2011 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Dec 16, 2011 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 16, 2011 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Dec 16, 2011 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 29, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Nov 28, 2011 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Nov 28, 2011 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Nov 28, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 9, 2011 | CNFR | R | FINAL REFUSAL WRITTEN |
| Jun 9, 2011 | GNFR | O | FINAL REFUSAL E-MAILED |
| Jun 9, 2011 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| May 18, 2011 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| May 18, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 18, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 25, 2011 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Feb 25, 2011 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of [ pain, ] cardiovascular disorders, [ alimentary tract and metabolism problems, ] respiratory diseases, [ endocrine, musculoskeletal, ] [ cardiopulmonary, ] [ genitourinary, oncological, hepatological, ophthalmological, otologicals, ] [ neurological, gastrointestinal, ] [ hormonal, dermatological and psychiatric ] [ related diseases and disorders ] [ and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators ]; hematological agents being pharmaceuticals for the treatment of hematological diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Devices for the administration of medicinal substances in powder form, namely, metered dose inhalers, dry powder inhalers and nebulizers; [ inhalers for medical purposes sold empty; ] aerosol dispensers for medical use [ ; injectable and infusion drug delivery systems; ] [ devices for cutaneous administration, namely, cutaneous applicators for applying pharmaceutical preparations; ] [ parts for the aforesaid apparatus ]
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the stylized wording "CHIESI" with a hexagon design having two detached sides forming an arrow pointing towards the wording. A small circle is displayed at one end of the arrow.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The English translation of "CHIESI" in the mark is "I ASKED".
Classification
International Classes
005
010